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Light is the main phase-adjusting stimulus of the circa-
dian clock located in the suprachiasmatic nucleus (SCN).
A candidate pathway transmitting photic information at
the postsynaptic site in the SCN is the extracellular signal-
regulated kinase (ERK 1/2) which has been previously
shown to be an essential element in the photoentrain-
ment of the circadian rhythm. An upstream activator of
the ERK signalling route is the small intracellular GTPase
Ras. Here we observed that endogenous Ras activity in the
SCN was subjected to rhythmic changes, reaching maxi-
mum levels at the late subjective day and minimum levels
at the late subjective night (CT22). In order to investigate
if Ras would modulate the circadian cycle, we used trans-
genic mice expressing constitutively activated Val-12 Ha-
Ras selectively in neurons (synRas mice). In these mice
Ras activity was also cycling during the circadian rhythm
yet, Ras activities were up-regulated at each time point
measured. We investigated if this change in Ras activity
translates into a behavioral phenotype by monitoring
free-running activity rhythms under conditions of con-
stant darkness. SynRas mice exhibited circadian rhythms
in locomotor activities similar to WT mice. However,
when challenged by applying a 15 minutes light pulse at
CT22 to promote phase advance shifts, synRas mice were
completely non-responsive. As a first step towards the
possible intracellular mechanism of this behavioral
change we analyzed ERK1/2 activities in more details: We
found a 1,7-fold increase of circadian peak levels of ERK
1/2 activities at CT10 and CT14 in synRas mice, while at
minimum levels (CT18, CT22) no differences were found
between ERK1/2 activities of WT and synRas mice. In WT
animals the 15 minutes light pulse at CT22 resulted in
rapid up regulations of Ras, ERK1/2 and CREB activities as
described previously by others. However, in correlation
with the lack of a behavioral response, ERK1/2 but not Ras
and CREB activities remained unchanged in synRas mice,
suggesting that Ras-dependent and Ras-independent
pathways may co-exist to regulate ERK1/2 and behavioral
phase shifts in response to the acute light treatment.
Next we investigated the length "tau" of the locomotor
activity rhythm during constant darkness and found a
slight shortening by about 10 minutes in synRas mice as
compared to the WT littermates. Recently, "tau" has been
discussed to be modulated by the interaction between gly-
cogen synthase 3β (GSK3β) and a clock gene product (Per
2) that is involved in the determination of circadian phase
durations. We describe here a down-regulation of GSK3β
phosphorylation in synRas mice as a possible mechanism
of "tau" shortening. Taken together, cycling of Ras activity
at elevated levels in the SCN during the circadian rhythm
results in a distinct pattern of behavioral phenotype
changes correlating with de-regulated ERK1/2 or GSK3β
activities.
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